AbbVie to acquire Allergan for $63bn

25-06-2019

AbbVie to acquire Allergan for $63bn

casimiropt / Shutterstock.com

US drug maker AbbVie has agreed to buy Allergan, the Ireland-headquartered maker of Botox, for $63 billion, in the latest blockbuster deal for the pharmaceutical industry.


Allergan, AbbVie, mergers and acquisitions, M&A, Botox, Brent Saunders, Richard Gonzalez, Humira

LSIPR